Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 2651 to 2675 of about 5880

Previous 25

Website Changes

09/13/2011

Sulfasalazine May Curtail Glioma-Related Seizures

09/13/2011

Pharma Strategy Blog: Roche files vismodegib for basal cell carcinoma with FDA [Editor`s note: although not for brain tumors - this may open the door for using it for some types of brain tumors]

09/13/2011

NIH-funded research points to potential therapy for tumor-associated epilepsy

09/12/2011

FDA Clears IsoRay`s GliaSite(R) Treatment for Brain Cancer

09/12/2011

ImmunoCellular Therapeutics Announces 55% Overall Survival at Three years from Phase I Study in Glioblastoma

38% of patients disease free at 3 years

09/10/2011

Human Cytomegaloviru s US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype.

09/09/2011

IBTA E NEWS AUGUST-SEPTEMBER 2011

09/09/2011

Flo`s 2nd Annual Chili Cook-Off - NJ

08/25/2011

Added: Trabedersen (AP 12009) to list of brain tumor treatments

08/23/2011

ABTA Seeks Novel Ideas to Award Its Research Discovery Grants

08/22/2011

Saturday Night Live Star Kenan Thompson to Host Third Annual Cristian Rivera Foundation Gala

08/21/2011

Mitchel Berger, UCSF brain surgeon, tops in nation

08/19/2011

Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.

08/19/2011

Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma.

08/19/2011

U of M cancer study could be chemo alternative

08/19/2011

Neurosurgical management and prognosis of patients with glioblastoma that progress during bevacizumab treatment.

08/15/2011

Buying College Textbooks? Reminder: Amazon Fundraiser!

08/07/2011

NWBT Announces Further Expansion of Clincal Sites in Ongoing Brain Cancer Trial

08/04/2011

Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis.

07/31/2011

Camp Jinka honored for innovative program

07/31/2011

IBTA E NEWS JULY 2011

07/31/2011

Drug-Induced Effects on Erlotinib Metabolism

07/28/2011

Bevacizumab (Avastin)and daily temozolomide (Temodar)for recurrent glioblastoma.

07/26/2011

Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer

07/25/2011

Threshold Pharmaceuticals Announces Initiation of Clinical Trial Evaluating TH-302 in Combination with Bevacizumab at University of Texas at San Antonio

Our privacy / cookie policy has changed.
Click HERE to read it!